首页> 外文期刊>Surgical innovation >Cost-effectiveness versus effective costliness.
【24h】

Cost-effectiveness versus effective costliness.

机译:成本效益与有效成本。

获取原文
获取原文并翻译 | 示例
       

摘要

In the United States we are sitting at a pivotal point for the future of surgical practice. Political pressures to radically change the way we do surgery are mounting daily as our present health care system begins to collapse under its own weight of costliness and inefficiencies. Cost-effectiveness is the new mantra of the present debates, and few could argue against the concerns expressed about the logarithmic escalation of the cost of medicine in the United States. The complaints are well worn: the United States spends more of its gross national product on health care than any other nation and yet ranks low in the overall health of its population. Up to 56% of our health care costs are spent in bureaucratic management costs by hospitals, insurance, and practitioners who are forced to maintain a massive infrastructure to sort out the myriad paperwork required by private (or public-though public tends to be simpler) insurers or regulatory agencies. Physicians are forced to maintain huge office staffs to deal with authorizations and billing as well as to practice extremes of defensive medicine to avoid potential astronomical law-suits. Hospitals have the same problems, as well as regional market competition and government regulation.
机译:在美国,我们正处于外科手术未来的关键时刻。从根本上改变我们做手术方式的政治压力每天都在增加,因为我们现有的医疗保健系统由于自身的成本高昂和效率低下而开始崩溃。成本效益是当前辩论的新口头禅,很少有人可以对美国对药品成本的对数上升表示的担忧进行争论。这些抱怨是陈词滥调:美国在医疗保健上的国民生产总值比任何其他国家都多,但在其总体健康水平上却排在低位。我们高达56%的医疗保健费用被医院,保险公司和从业人员用于官僚管理费用,这些医院,保险公司和从业人员被迫维护庞大的基础设施,以整理私人(或公共场所,尽管公共场所通常更简单)所需的大量文书工作。保险公司或监管机构。医师被迫维持庞大的办公室人员来处理授权和账单,并采取极端的防御性医学措施以避免潜在的天文诉讼。医院,区域市场竞争和政府监管也存在同样的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号